Amanote Research
Register
Sign In
Benefits Afforded by Combined Temozolomide, Radiation and Stem Cell Strategy for Glioma Therapy
Tropical Journal of Pharmaceutical Research
- Nigeria
doi 10.4314/tjpr.v16i6.16
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pharmacology
Pharmaceutical Science
Date
July 4, 2017
Authors
Bin Li
Fei Wang
Jian Hai
Publisher
African Journals Online (AJOL)
Related search
Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
The Strategy for Enhancing Temozolomide Against Malignant Glioma
Frontiers in Oncology
Cancer Research
Oncology
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Lipolytic Inhibitor G0S2 Modulates Glioma Stem-Like Cell Radiation Response
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Hyperthermia Sensitizes Glioma Stem Cells to Radiation by Inhibiting AKT
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Bevacizumab Monotherapy for Temozolomide-Refractory Malignant Glioma
Japanese Journal of Neurosurgery
Surgery
Neurology
Correction To: Lipolytic Inhibitor G0S2 Modulates Glioma Stem-Like Cell Radiation Response
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells
Frontiers in Neurology
Neurology
Evaluation of Radiation Therapy and Chemotherapy Combined With Nephrectomy for Renal Cell Carcinoma
Japanese Journal of Urology
Urology